Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Current Taxes (2021 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Current Taxes for 5 consecutive years, with $683000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Current Taxes changed N/A year-over-year to $683000.0, compared with a TTM value of $683000.0 through Mar 2025, changed N/A, and an annual FY2024 reading of $871000.0, changed N/A over the prior year.
  • Current Taxes was $683000.0 for Q1 2025 at Agios Pharmaceuticals, down from $871000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $52.7 million in Q3 2024 and bottomed at $683000.0 in Q1 2025.
  • Average Current Taxes over 3 years is $13.8 million, with a median of $7.6 million recorded in 2021.